Industry Analysis & Industry Trends
The Contract Pharmaceutical Research Services industry experienced hefty growth in the five years to 2014. Growth will slow slightly in the five years to 2019, but not enough to harm the industry. This is because pharmaceutical companies will continue to fund research and development to find effective new drugs.... purchase to read more
Industry Report - Industry Analysis Chapter
Operators in the Contract Pharmaceutical Research Services industry provide a breadth of research and development services to downstream clients in the pharmaceutical industries. In an effort to control costs, achieve greater research productivity and reduce risk, drug manufacturers are increasingly outsourcing their research and development (R&D) functions to industry operators, also referred to as contract research organizations (CRO). In addition, CROs offer drug development expertise and capabilities not found internally, allowing drug developers to scale production more quickly and bring their products to the market.
The advantages offered by CROs have precipitated rapid industry growth in the past five years... purchase to read more